We recently published a list of 10 Best Performing Growth Stocks in 2025 In this article, we are going to take a look at where Zai Lab Limited (NASDAQ:ZLAB) stands against other best performing ...

JPMorgan raised the firm’s price target on Zai Lab (ZLAB) to $51 from $44 and keeps an Overweight rating on the shares. The firm updated models in the small-cap biotechnology space. Published ...

Investors in Zai Lab Limited (NASDAQ:ZLAB) had a good week, as its shares rose 2.5% to close at US$34.64 following the release of its annual results. Revenue hit US$399m in line with forecasts ...

Zai Lab (ZLAB) “announced that China’s National Medical Products Administration has accepted the Biologics License Application for TIVDAK, tisotumab vedotin-tftv, for the treatment of patients ...

A live webcast of the fireside chat will be available on the Investor Relations page of Zai Lab’s website at ir.zailaboratory.com/webcasts-presentations and ...

Zai Lab (ZLAB – Research Report) received a Buy rating and a $55.00 price target from Scotiabank analyst Louise Chen today. The company’s shares opened today at $35.16. See what stocks are ...

Shares of Zai Lab Limited Unsponsored ADR (ZLAB) have gained 15.9% over the past four weeks to close the last trading session at $31.73, but there could still be a solid upside left in the stock ...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following ...